Vimarsana
Biggest News Aggregation in the World

Page 37 - Ar T News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ar T Today - Breaking & Trending Today

Sana Biotechnology Presentations at 2021 ASH Annual Meeting - Vimarsana News

Sana Biotechnology Presentations at 2021 ASH Annual Meeting

Hypoimmune CAR T cells evade both innate and adaptive immune systems in murine models, even in animals with pre-existing immunity to CAR T cells CD8- and...

'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete - Vimarsana News

'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete

Chemotherapy, the decades-old approach to second-line therapy for relapsed/refractory large B cell lymphomas, may soon be obsolete, investigators say.

Mr. T's Outstanding Holiday Words of Wisdom Put BLM's Thanksgiving Scolding to Shame – RedState - Vimarsana News

Mr. T's Outstanding Holiday Words of Wisdom Put BLM's Thanksgiving Scolding to Shame – RedState

This is how it's done.

Biolife Solutions opens new facility in Amsterdam - Vimarsana News

Biolife Solutions opens new facility in Amsterdam

Biolife Solutions and its subsidiary SciSafe have opened a new 40,000 square-foot biorepository Center of Excellence in Amsterdam, located next to Schiphol Airport.

Fierce Pharma Asia—Hansoh's siRNA deals; J&J preps for Legend's CAR-T launch; Brii's COVID antibodies - Vimarsana News

Fierce Pharma Asia—Hansoh's siRNA deals; J&J preps for Legend's CAR-T launch; Brii's COVID antibodies

China's Hansoh Pharma inked two siRNA partnerships. Johnson & Johnson intends to roll out a tailored patient support program for Legend Biotech's upcoming CAR-T therapy. Brii Biosciences' COVID-19 antibody combo could be a blockbuster opportunity, one analyst said. And more.